Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402

PURPOSE: In low–tumor burden follicular lymphoma (FL), maintenance rituximab (MR) has been shown to improve progression-free survival when compared with observation. It is not known whether MR provides superior long-term disease control compared with re-treatment rituximab (RR) administered on an as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kahl, Brad S., Hong, Fangxin, Williams, Michael E., Gascoyne, Randy D., Wagner, Lynne I., Krauss, John C., Habermann, Thomas M., Swinnen, Lode J., Schuster, Stephen J., Peterson, Christopher G., Sborov, Mark D., Martin, S. Eric, Weiss, Matthias, Ehmann, W. Christopher, Horning, Sandra J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2014
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171355/
https://ncbi.nlm.nih.gov/pubmed/25154829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.56.5853
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados